Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    March 2019
  1. CAO Y, Yang Q, Deng H, Tang J, et al
    Transcriptional factor ATF3 protects against colitis by regulating follicular helper T cells in Peyer's patches.
    Proc Natl Acad Sci U S A. 2019;116:6286-6291.
    PubMed     Text format     Abstract available


    January 2019
  2. LI Y, Fuhrer M, Bahrami E, Socha P, et al
    Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases.
    Proc Natl Acad Sci U S A. 2019;116:970-975.
    PubMed     Text format     Abstract available


    October 2018
  3. YANG Z, Li Q, Wang X, Jiang X, et al
    C-type lectin receptor LSECtin-mediated apoptotic cell clearance by macrophages directs intestinal repair in experimental colitis.
    Proc Natl Acad Sci U S A. 2018;115:11054-11059.
    PubMed     Text format     Abstract available


  4. NAGAHAMA Y, Shimoda M, Mao G, Singh SK, et al
    Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism.
    Proc Natl Acad Sci U S A. 2018;115:11036-11041.
    PubMed     Text format     Abstract available


  5. LOPETUSO LR, De Salvo C, Pastorelli L, Rana N, et al
    IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
    Proc Natl Acad Sci U S A. 2018;115:E9362-E9370.
    PubMed     Text format     Abstract available


    September 2018
  6. GARCIA-CARBONELL R, Wong J, Kim JY, Close LA, et al
    Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death.
    Proc Natl Acad Sci U S A. 2018;115:E9192-E9200.
    PubMed     Text format     Abstract available


    May 2018
  7. NGO VL, Abo H, Maxim E, Harusato A, et al
    A cytokine network involving IL-36gamma, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage.
    Proc Natl Acad Sci U S A. 2018;115:E5076-E5085.
    PubMed     Text format     Abstract available


  8. DIAS AM, Correia A, Pereira MS, Almeida CR, et al
    Metabolic control of T cell immune response through glycans in inflammatory bowel disease.
    Proc Natl Acad Sci U S A. 2018 May 2. pii: 1720409115.
    PubMed     Text format     Abstract available


    January 2018
  9. HAN J, Jackson D, Holm J, Turner K, et al
    Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1712625115.
    PubMed     Text format     Abstract available


    October 2017
  10. LESHCHINER ES, Rush JS, Durney MA, Cao Z, et al
    Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.
    Proc Natl Acad Sci U S A. 2017;114:11392-11397.
    PubMed     Text format     Abstract available


  11. XUE X, Bredell BX, Anderson ER, Martin A, et al
    Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201712946.
    PubMed     Text format     Abstract available


    February 2017
  12. CHAO KL, Kulakova L, Herzberg O
    Gene polymorphism linked to increased asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein.
    Proc Natl Acad Sci U S A. 2017 Feb 1. pii: 201616783.
    PubMed     Text format     Abstract available


    December 2016
  13. KUDELKA MR, Hinrichs BH, Darby T, Moreno CS, et al
    Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk.
    Proc Natl Acad Sci U S A. 2016 Dec 7. pii: 201612158.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: